WO2001094529A3 - Nouveau polypeptide, serine hydrolase humaine atp-dependante 21, et polynucleotide codant pour ce polypeptide - Google Patents

Nouveau polypeptide, serine hydrolase humaine atp-dependante 21, et polynucleotide codant pour ce polypeptide Download PDF

Info

Publication number
WO2001094529A3
WO2001094529A3 PCT/CN2001/000658 CN0100658W WO0194529A3 WO 2001094529 A3 WO2001094529 A3 WO 2001094529A3 CN 0100658 W CN0100658 W CN 0100658W WO 0194529 A3 WO0194529 A3 WO 0194529A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
polynucleotide encoding
serine proteinase
human atp
discloses
Prior art date
Application number
PCT/CN2001/000658
Other languages
English (en)
Chinese (zh)
Other versions
WO2001094529A2 (fr
Inventor
Yumin Mao
Yi Xie
Original Assignee
Shanghai Biowindow Gene Dev
Yumin Mao
Yi Xie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Dev, Yumin Mao, Yi Xie filed Critical Shanghai Biowindow Gene Dev
Priority to AU85648/01A priority Critical patent/AU8564801A/en
Publication of WO2001094529A2 publication Critical patent/WO2001094529A2/fr
Publication of WO2001094529A3 publication Critical patent/WO2001094529A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un nouveau polypeptide, une sérine hydrolase humaine ATP-dépendante 21, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la sérine hydrolase humaine ATP-dépendante 21.
PCT/CN2001/000658 2000-04-29 2001-04-28 Nouveau polypeptide, serine hydrolase humaine atp-dependante 21, et polynucleotide codant pour ce polypeptide WO2001094529A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU85648/01A AU8564801A (en) 2000-04-29 2001-04-28 A novel polypeptide, a human atp dependant serine proteinase 21 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00115512A CN1321768A (zh) 2000-04-29 2000-04-29 一种新的多肽——人atp依赖的丝氨酸蛋白水解酶21和编码这种多肽的多核苷酸

Publications (2)

Publication Number Publication Date
WO2001094529A2 WO2001094529A2 (fr) 2001-12-13
WO2001094529A3 true WO2001094529A3 (fr) 2002-05-02

Family

ID=4584958

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000658 WO2001094529A2 (fr) 2000-04-29 2001-04-28 Nouveau polypeptide, serine hydrolase humaine atp-dependante 21, et polynucleotide codant pour ce polypeptide

Country Status (3)

Country Link
CN (1) CN1321768A (fr)
AU (1) AU8564801A (fr)
WO (1) WO2001094529A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7103563B1 (en) 2000-03-21 2006-09-05 America Online, Inc. System and method for advertising with an internet voice portal
CA2516455C (fr) 2003-02-20 2012-05-01 Seattle Genetics, Inc. Conjugues de medicaments anticorps anti-cd70, utilisation desdits conjugues dans le traitement du cancer et des troubles immunitaires

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999063073A1 (fr) * 1998-05-21 1999-12-09 The Trustees Of Columbia University In The City Of New York Pak4 un nouveau gene codant pour une serine/threonine kinase
US6013464A (en) * 1995-01-06 2000-01-11 Onyx Pharmaceuticals, Inc. Human PAK65

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013464A (en) * 1995-01-06 2000-01-11 Onyx Pharmaceuticals, Inc. Human PAK65
WO1999063073A1 (fr) * 1998-05-21 1999-12-09 The Trustees Of Columbia University In The City Of New York Pak4 un nouveau gene codant pour une serine/threonine kinase

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MORI, E. ET AL.: "Cloning, nucleotide sequencing and expression of the azospirillum brasilense ion gene: involvement in iron uptake", J. BACTERIOL., vol. 178, no. 12, 1996, pages 3440 - 3446 *
STEPHENS, R.S. ET AL.: "Genome sequence of an obligate intracellular pathogen of humans: chlamydia trachomatis", SCIENCE, vol. 282, no. 5389, 1998, pages 754 - 759 *
SULSTON, J.E. AND WATERSTON, R.: "Toward a complete human genome sequence", GENOME RES., vol. 8, no. 11, 1998, pages 1097 - 1108 *

Also Published As

Publication number Publication date
WO2001094529A2 (fr) 2001-12-13
AU8564801A (en) 2001-12-17
CN1321768A (zh) 2001-11-14

Similar Documents

Publication Publication Date Title
WO2001094529A3 (fr) Nouveau polypeptide, serine hydrolase humaine atp-dependante 21, et polynucleotide codant pour ce polypeptide
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001083688A3 (fr) Nouveau polypeptide, sous-unite humaine 13 phosphatidylinositol-4-phosphate-5-kinase ii beta, et polynucleotide codant pour ce polypeptide
WO2001088084A3 (fr) Nouveau polypeptide, superoxyde dismutase 11, et polynucleotide codant pour ce polypeptide
WO2001083687A3 (fr) Nouveau polypeptide, proteine pax humaine 23, et polynucleotide codant pour ce polypeptide
WO2001040484A3 (fr) Nouveau polypeptide, serine protease humaine 64 atp-dependante, et polynucleotide codant pour ce polypeptide
WO2001075016A3 (fr) Nouveau polypeptide, tyrosinase humaine 16, et polynucleotide codant pour ce polypeptide
WO2001081538A3 (fr) Nouveau polypeptide, connexine humaine 9, et polynucleotide codant pour ce polypeptide
WO2001077286A3 (fr) Nouveau polypeptide, globine humaine 58 de l'uterus, et un polynucleotide codant pour ce polypeptide
WO2001075011A3 (fr) Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide
WO2001075042A3 (fr) Nouveau polypeptide, serine hydrolase humaine atp-dependante 9, et polynucleotide codant pour ce polypeptide
WO2001075004A3 (fr) Nouveau polypeptide, enzyme de conjugaison de l'ubiquitine 9, et polynucléotide codant pour ce polypeptide
WO2001077285A3 (fr) Nouveau polypeptide, proteine 13 de la famille des amidases, et polynucleotide codant pour ce polypeptide
WO2001083681A3 (fr) Nouveau polypeptide, dihydroorotase humaine 21, et polynucleotide codant pour ce polypeptide
WO2001075058A3 (fr) Nouveau polypeptide, aminoacyl-arnt synthetase humaine 15 de type ii, et polynucleotide codant pour ce polypeptide
WO2001075007A3 (fr) Nouveau polypeptide, tyrosinase 15, et polynucléotide codant pour ce polypeptide
WO2001079433A3 (fr) Nouveau polypeptide, facteur humain de transcription de la differentiation cellulaire 13, et polynucleotide codant pour ce polypeptide
WO2001081536A3 (fr) Nouveau polypeptide, proteine kinase ysk1 humaine 10, et polynucleotide codant pour ce polypeptide
WO2001083683A3 (fr) Nouveau polypeptide, proteine pax humaine 11.3, et polynucleotide codant pour ce polypeptide
WO2001083675A3 (fr) Nouveau polypeptide, serine hydrolase humaine atp-dependante 10.2, et polynucleotide codant pour ce polypeptide
WO2001075022A3 (fr) Nouveau polypeptide, eucaryon acetyl transferase humaine 12, et polynucleotide codant pour ce polypeptide
WO2001075026A3 (fr) Nouveau polypeptide, eucaryote acetyl transferase humaine 10, et polynucleotide codant pour ce polypeptide
WO2001075039A3 (fr) Nouveau polypeptide, arn helicase humaine 10, et polynucleotide codant pour ce polypeptide
WO2001079431A3 (fr) Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide
WO2001064866A1 (fr) Nouveau polypeptide, ribosome s19e 11, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP